Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03967847 · ClinicalTrials.gov registry record · Phase 3
Oral Ketorolac for Arthroscopic Rotator Cuff Repair
A Phase 3 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 44
- Enrollment target
NCT03967847 is a Phase 3 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 44 participants.
The verdict
NCT03967847, a Phase 3 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 44 participants
- Enrollment target
Study Summary
1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following arthroscopic rotator cuff repair. 2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the standard of care pain protocol will reduce postoperative opioid consumption following arthroscopic rotator cuff repair.
Interventions
- DRUG Ketorolac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2019-02-11 |
| Est. Completion | 2021-05-17 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03967847
The ClinicalTrials.gov registry entry for NCT03967847 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketorolac is the first listed.
NCT03967847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03967847 about?
NCT03967847 is a clinical study titled "Oral Ketorolac for Arthroscopic Rotator Cuff Repair". 1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following arthroscopic rotator cuff repair. 2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the stand...
What is the current status of trial NCT03967847?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 44 participants. The study started on 2019-02-11. Estimated completion is 2021-05-17.
What interventions are being tested in trial NCT03967847?
The interventions under investigation include: Ketorolac (DRUG).
Who is sponsoring clinical trial NCT03967847?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.